Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion (068270) to Additionally List 63,385 Common Shares Following Exercise of Stock Options

Posted on May 9, 2024July 16, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) to Additionally List 63,385 Common Shares Following Exercise of Stock Options

Fact Source: Financial Supervisory Service (DART) / 2024-05-09

Disclosure Type: Additional Listing (Exercise of Stock Option)

💡 3-Second Summary

Celltrion will additionally list 63,385 newly issued common shares on May 14, 2024, resulting from the exercise of stock options.

📊 1. [Summary of Core Disclosure Content and Major Figures]

  • Type and Number of Additional Shares: 63,385 registered common shares
  • Method of Capital Increase: Exercise of stock options
  • Issue Price per Share by Round (Par Value: KRW 1,000):
    • Round 128: KRW 52,697 (479 shares)
    • Round 129: KRW 86,161 (4,956 shares)
    • Round 130: KRW 78,213 (41,745 shares)
    • Round 131: KRW 169,828 (770 shares)
    • Round 132: KRW 134,308 (12,435 shares)
    • Round 133: KRW 170,330 (1,591 shares)
    • Round 134: KRW 140,017 (1,409 shares)
  • Key Timeline:
    • Issue Date: April 26, 2024
    • Listing Date: May 14, 2024
    • Dividend Baseline Date: January 01, 2024 (Fiscal year-end: Dec 31)
  • Stock Code: 068270 (Standard Code: KR7068270008)

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

  • Increase in Outstanding Shares: This filing officially records the upcoming listing of 63,385 new common shares generated through the exercise of stock options, resulting in an expansion of the outstanding share count.
  • Pricing Distribution across Different Rounds: The issue prices for these shares vary by round, ranging from a minimum of KRW 52,697 (Round 128) to a maximum of KRW 170,330 (Round 133), as presented in the quantitative data.
  • No Financial Performance Causes Specified: This disclosure reports an administrative update on stock listing. It does not contain any details regarding historical financial fluctuations or concrete causes behind operational performance.

📝 Editor’s Comment (by K-STOCK Editor)

Celltrion’s latest filing announces that 63,385 common shares will be newly listed on May 14, 2024, following the exercise of previously granted stock options. This marks the conclusion of the administrative and capital increase process resulting from the exercise of these options.

For investors reviewing this update, the primary metrics to observe are the ‘volume of the newly listed shares’ and the ‘discrepancy between the exercise prices and the current market price.’ The addition consists of 63,385 shares, with exercise prices ranging from KRW 52,697 to KRW 170,330. As the disclosure is limited to the details of the listing and does not specify the identity of the option exercisers or the nature of the options, investors are advised to objectively monitor the actual market flow and supply-demand fluctuations of these shares starting from the listing date.

📢 Disclaimer & Source Information

Source: This content was restructured and newly drafted based on the official submitted data from the Financial Supervisory Service (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial liabilities rest entirely with the individual investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hanwha Aerospace (012450) – Contract Signed with PPS for Next-Generation Launch Vehicle Development Project (KRW 950.5B)
Next Post: [Disclosure] Celltrion (068270) Reports Q1 2024 Tentative Revenue of KRW 736.9 Billion (+23.33% YoY) and Operating Profit of KRW 15.4 Billion (-91.54% YoY)

Related Posts

[Disclosure] Hanwha Ocean (042660) Amends Paid-in Capital Increase for Subsidiary Hanwha Ocean USA Holdings Corp., Adjusting Operating Funds and Securities Acquisition Funds Disclosures
[Disclosure] Hanwha Aerospace (012450) – Contract Signed with PPS for Next-Generation Launch Vehicle Development Project (KRW 950.5B) Disclosures
[Disclosure] SK square (402340) Subsidiary SK hynix Amends Timeline for $10B US AI Unit Capital Injection to March 2030 Semiconductors
[Disclosure] SK Square (402340) Discloses Subsidiary SK Hynix’s Successful ADR Listing on the U.S. NASDAQ Market Disclosures
[Disclosure] SK Hynix (000660) – Response to Inquiry on U.S. Listing Rumors: Approves 15.3 Million Treasury Share Cancellation Semiconductors
[Disclosure] Jusung Engineering (036930) to Host 2-Day Domestic NDR in Yeouido & Jongno on June 3-4: 1:1 Meetings with Global Institutions Sponsored by Mirae Asset Securities Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme